Trametinib dimethyl sulfoxide
Used for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment. It has a role as an antineoplastic agent and an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor.
| Catalog Number | API1187431431 |
| Alternative Name(s) | Trametinib DMSO solvate TRAMETINIB DIMETHYL SULFOXIDE Trametinib DMSO Trametinib (DMSO solvate) |
| Research Area | Anti-Tumor APIs |
| Molecular Formula | C28H29FIN5O5S |
| CAS# | 1187431-43-1 |
| SMILES | CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5.CS(=O)C |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/trametinib-dimethyl-sulfoxide-item-11878.html |